COVID-19 Impact on Global Point of Care or HIV Self-Test Market

1. Point of Care/ HIV Self-Test Market Size – Forecast to 2026 As per the research conducted by GME, the Point of Care/ HIV Self-Test Market will grow with a CAGR value of12.2 percent. The market will foresee a rise in its revenue size owing to a major driver i.e. increasing research and development activities to launch fourth generation technology based test kits which offers testing of IgG and IgM both simultaneously. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Point of Care/ HIV Self-Test Market- Forecast to 2026" Browse the Report @ https://www.globalmarketestimates.com/market-report/global-point-of-care-or-hiv- self-test-market-3118 By Sample Type (Urine Sample & Blood Sample), By Technology (Second Generation Self-Test, Third Generation Self-Test, and Fourth Generation Self-Test), By Product Type (Self Sampling and Self- Testing), By End-User (Home Healthcare, Hospitals & Clinics, E-Commerce Channels and Diagnostic Laboratories), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis Key Market Insights Human Immunodeficiency Virus or most popularly called as HIV is a virus that attacks healthy cells of the body which are responsible to maintain the immune system The market of clinical diagnostics has been seeing an increasing trend of using home based or at- home or self-test HIV kits to rule out the possible HIV infection cases at point of care level The 2nd generation technology will be the top segment in terms of revenue sales during the forecast period Atomo Diagnostics, Everlywell, autotest VIH, Biosure UK, SimplitudeByMe, Self Care Ltd., OraSure Technologies, Private iDNA, MyLAB Box, LetsGetChecked, Biosynex Group, bioLytical Laboratories Inc., Orange Life, Bedfordbiotech, Sedia Biosciences Corporation, and Chembio Diagnostic Systems are the players in the point of care/ HIV self-test market Browse the Report @ https://www.globalmarketestimates.com/market-report/global-point-of-care-or-hiv- self-test-market-3118 Sample Type Outlook (Revenue, USD Billion, 2021-2026)

2. Blood Urine Product Type Outlook (Revenue, USD Billion, 2021-2026) Self-Sampling Self-Testing Technology Outlook (Revenue, USD Billion, 2021-2026) Second Generation Self-Test Third Generation Self-Test Fourth Generation Self-Test End-User Outlook (Revenue, USD Billion, 2021-2026) Home Healthcare Hospitals & Clinics E-Commerce Channels Diagnostic Laboratories Regional Outlook (Revenue, USD Billion, 2021-2026) North America The U.S. Canada Mexico Europe Germany UK France Spain Italy Rest of Europe Asia Pacific China India Japan

3. South Korea Australia Rest of APAC Central & South America Brazil Argentina Rest of CSA Middle East & Africa Saudi Arabia UAE Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php